TickerFacts.

Royalty Pharma plc (RPRX): EPS (Diluted)

Annual figures by period end, from SEC filings.

$1.78
Year ended 2025-12-31
+161.1%
3-year compound annual growth
+6.2%
5-year compound annual growth
$2.532020-12-31: $1.322021-12-31: $1.492022-12-31: $0.102023-12-31: $2.532024-12-31: $1.912025-12-31: $1.78$1.78
2020-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$1.78-6.8%2026-02-11, From 2025-01-01
2024-12-31$1.91-24.5%2026-02-11, From 2024-01-01
2023-12-31$2.53n/m2026-02-11, From 2023-01-01
2022-12-31$0.10-93.3%2025-02-12, From 2022-01-01
2021-12-31$1.49+12.9%2024-02-15, From 2021-01-01
2020-12-31$1.32n/a2023-02-15, From 2020-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Royalty Pharma plc (RPRX)2025-12-31$1.78-6.8%
Sarepta Therapeutics, Inc. (SRPT)2025-12-31-$7.13n/m
Amneal Pharmaceuticals, Inc. (AMRX)2025-12-31$0.22n/m
United Therapeutics Corp (UTHR)2025-12-31$27.86+13.1%
BioMarin Pharmaceutical Inc (BMRN)2025-12-31$1.80-18.6%
PTC Therapeutics, Inc. (PTCT)2025-12-31$7.78n/m
Alnylam Pharmaceuticals, Inc. (ALNY)2025-12-31$2.33n/m
Phibro Animal Health Corp (PAHC)2026-06-30$2.43+104.2%
Alkermes plc. (ALKS)2025-12-31$1.43-34.1%

Compare RPRX, SRPT, AMRX, UTHR side by side · Screen every company in Pharmaceutical Preparations ↗